Pay in 4 interest-free payments of $24.75 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
In pancreatic carcinoma (MIA PaCa-2) and melanoma (A375) xenograft model
is a potent ErbB inhibitor for the treatment of cancer
and STAT-3
It induces neuronal differentiation in human cortical neuronal cells (HCN)
23)/b22-21+
GPR39-C3 - GPR39 Agonist. CAS# 1621175-65-2 size:2 mg solid In pancreatic carcinoma (MIA PaCa-2)GPR39 C3, CAS No. 1621175 65 2, is the first potent, selective and orally bioavailable GPR39 agonist with an EC50 ~0. 8 nM for human GPR39 and ~0. 4 nM for rodent GPR39. It has no inhibitory effects (at 10 M) on a panel of kinases and exhibits no relevant binding affinity for the related ghrelin and neurotensin 1 receptors and other enzymes, transporters, and GPCRs. GPR39 C3 has excellent functional activity in physiologically relevant rodent cells
US$ 3142.00
US$ 1516.00
US$ 1437.00
US$ 2776.50
US$ 1069.50
US$ 1364.50
US$ 2167.00
US$ 1854.00
US$ 1279.00
US$ 18250.00